| 000 | 01823 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513213322.0 | ||
| 264 | 0 | _c20000727 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.2000.2939 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYokoyama, Y | |
| 245 | 0 | 0 |
_aThe 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJun 2000 |
||
| 300 |
_a316-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a5' Untranslated Regions _xgenetics |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCatalytic Domain _xgenetics |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xgenetics |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGenetic Vectors _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aNucleic Acid Conformation |
| 650 | 0 | 4 |
_aPoly A _xgenetics |
| 650 | 0 | 4 | _aRNA |
| 650 | 0 | 4 |
_aRNA, Antisense _xchemistry |
| 650 | 0 | 4 |
_aRNA, Catalytic _xchemistry |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTelomerase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aTakahashi, Y | |
| 700 | 1 | _aShinohara, A | |
| 700 | 1 | _aWan, X | |
| 700 | 1 | _aTakahashi, S | |
| 700 | 1 | _aNiwa, K | |
| 700 | 1 | _aTamaya, T | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 273 _gno. 1 _gp. 316-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2000.2939 _zAvailable from publisher's website |
| 999 |
_c10824322 _d10824322 |
||